Patient-perceived outcomes of an inpatient PPI therapeutic interchange program

Kimberly A. Galt, Michael A. Galt, Michelle M. Sodorff, Paul Turner, Jason E. Lambrecht

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We conducted a prospective study examining the impact of a hospital-based PPI automatic therapeutic interchange program on patient-perceived clinical and humanistic outcomes. Patients talking omeprazole before being hospitalized were switched to the hospital's preferred PPI, lansoprazole; while those taking lansoprazole prior to hospitalization continued on lansoprazole on an inpatient basis. No differences were observed between the two patient groups with regard to demographics, GI symptom severity scores, or satisfaction or expectations associated with their inpatient PPI therapy at either admission or discharge (p > 0.05). A significant improvement in patient-perceived GI symptom severity was observed within each group from admission to discharge (p <0.01). Some 37% of patients whose medication was interchanged were unaware that this interchange occurred during their hospital stay. A hospital-based PPI therapeutic interchange program did not adversely affect patient-perceived outcomes of PPI therapy.

Original languageEnglish
Pages (from-to)340-354
Number of pages15
JournalFormulary
Volume36
Issue number5
StatePublished - May 2001

Fingerprint

Inpatients
Lansoprazole
Therapeutics
Omeprazole
Length of Stay
Hospitalization
Demography
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Galt, K. A., Galt, M. A., Sodorff, M. M., Turner, P., & Lambrecht, J. E. (2001). Patient-perceived outcomes of an inpatient PPI therapeutic interchange program. Formulary, 36(5), 340-354.

Patient-perceived outcomes of an inpatient PPI therapeutic interchange program. / Galt, Kimberly A.; Galt, Michael A.; Sodorff, Michelle M.; Turner, Paul; Lambrecht, Jason E.

In: Formulary, Vol. 36, No. 5, 05.2001, p. 340-354.

Research output: Contribution to journalArticle

Galt, KA, Galt, MA, Sodorff, MM, Turner, P & Lambrecht, JE 2001, 'Patient-perceived outcomes of an inpatient PPI therapeutic interchange program', Formulary, vol. 36, no. 5, pp. 340-354.
Galt KA, Galt MA, Sodorff MM, Turner P, Lambrecht JE. Patient-perceived outcomes of an inpatient PPI therapeutic interchange program. Formulary. 2001 May;36(5):340-354.
Galt, Kimberly A. ; Galt, Michael A. ; Sodorff, Michelle M. ; Turner, Paul ; Lambrecht, Jason E. / Patient-perceived outcomes of an inpatient PPI therapeutic interchange program. In: Formulary. 2001 ; Vol. 36, No. 5. pp. 340-354.
@article{fa0c4152490849fabc126f18a95df129,
title = "Patient-perceived outcomes of an inpatient PPI therapeutic interchange program",
abstract = "We conducted a prospective study examining the impact of a hospital-based PPI automatic therapeutic interchange program on patient-perceived clinical and humanistic outcomes. Patients talking omeprazole before being hospitalized were switched to the hospital's preferred PPI, lansoprazole; while those taking lansoprazole prior to hospitalization continued on lansoprazole on an inpatient basis. No differences were observed between the two patient groups with regard to demographics, GI symptom severity scores, or satisfaction or expectations associated with their inpatient PPI therapy at either admission or discharge (p > 0.05). A significant improvement in patient-perceived GI symptom severity was observed within each group from admission to discharge (p <0.01). Some 37{\%} of patients whose medication was interchanged were unaware that this interchange occurred during their hospital stay. A hospital-based PPI therapeutic interchange program did not adversely affect patient-perceived outcomes of PPI therapy.",
author = "Galt, {Kimberly A.} and Galt, {Michael A.} and Sodorff, {Michelle M.} and Paul Turner and Lambrecht, {Jason E.}",
year = "2001",
month = "5",
language = "English",
volume = "36",
pages = "340--354",
journal = "Formulary",
issn = "1082-801X",
publisher = "Advanstar Communications",
number = "5",

}

TY - JOUR

T1 - Patient-perceived outcomes of an inpatient PPI therapeutic interchange program

AU - Galt, Kimberly A.

AU - Galt, Michael A.

AU - Sodorff, Michelle M.

AU - Turner, Paul

AU - Lambrecht, Jason E.

PY - 2001/5

Y1 - 2001/5

N2 - We conducted a prospective study examining the impact of a hospital-based PPI automatic therapeutic interchange program on patient-perceived clinical and humanistic outcomes. Patients talking omeprazole before being hospitalized were switched to the hospital's preferred PPI, lansoprazole; while those taking lansoprazole prior to hospitalization continued on lansoprazole on an inpatient basis. No differences were observed between the two patient groups with regard to demographics, GI symptom severity scores, or satisfaction or expectations associated with their inpatient PPI therapy at either admission or discharge (p > 0.05). A significant improvement in patient-perceived GI symptom severity was observed within each group from admission to discharge (p <0.01). Some 37% of patients whose medication was interchanged were unaware that this interchange occurred during their hospital stay. A hospital-based PPI therapeutic interchange program did not adversely affect patient-perceived outcomes of PPI therapy.

AB - We conducted a prospective study examining the impact of a hospital-based PPI automatic therapeutic interchange program on patient-perceived clinical and humanistic outcomes. Patients talking omeprazole before being hospitalized were switched to the hospital's preferred PPI, lansoprazole; while those taking lansoprazole prior to hospitalization continued on lansoprazole on an inpatient basis. No differences were observed between the two patient groups with regard to demographics, GI symptom severity scores, or satisfaction or expectations associated with their inpatient PPI therapy at either admission or discharge (p > 0.05). A significant improvement in patient-perceived GI symptom severity was observed within each group from admission to discharge (p <0.01). Some 37% of patients whose medication was interchanged were unaware that this interchange occurred during their hospital stay. A hospital-based PPI therapeutic interchange program did not adversely affect patient-perceived outcomes of PPI therapy.

UR - http://www.scopus.com/inward/record.url?scp=0035036463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035036463&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 340

EP - 354

JO - Formulary

JF - Formulary

SN - 1082-801X

IS - 5

ER -